Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- DRUG: Tislelizumab
- DRUG: Pemetrexed
Sponsor
Seoul National University Hospital
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]